Measles virus (MV),
Introduction
Measles is an acute, highly contagious viral disease causing almost 1 million deaths annually. The main complications of measles are pneumonia, encephalitis and secondary bacterial infections due to transient immunosuppression (reviewed in Katz, 1995) . Despite the strong immunosuppressive effects in vivo, acute measles virus (MV) infection induces life-long immunity. This was first observed during an epidemic in the Faroe Islands when only inhabitants who had had measles 65 years earlier escaped infection (Panum, 1940) . In contrast, immunization with attenuated measles vaccine does not seem to induce life-long protection as documented by outbreaks in populations that had been vaccinated 15 to 20 years earlier (Gustafson et al., 1987 ; Chen et al., 1990) .
The immunological factors which determine the outcome of the disease and which lead to life-long immunity against measles are poorly understood. However, T-cell-mediated immunity seems to play a central role in the clearance of established MV infection and in protection against reinfection. This assumption is strongly supported by indirect evidence : although MV infection induces both humoral and cell-mediated responses, agammaglobulinaemic children recover from infection and develop immunity against measles, whereas those with T-cell anomalies suffer the most severe complications (Burnet, 1968) .
However, cell-mediated immunity against MV has been difficult to investigate. The reason for this is the strong immunosuppressive effects exhibited by infectious MV in vitro. Peripheral blood lymphocytes from patients with acute measles as well as in vitro infected PBMC exhibit a state of unresponsiveness to mitogenic stimulation. Cell cycle analysis has shown that both T-and B-lymphocytes are arrested in late G " when stimulated with mitogen in the presence of infectious MV (McChesney & Oldstone, 1989 ; Engelking et al., 1999) .
Despite experimental difficulties due to immunosuppression, there is also direct evidence for the involvement of CD4 + and CD8 + T-lymphocytes in immunity to measles (Jacobson et al., 1984 ; Van Binnendijk et al., 1990 ; Nanan et al., 1995 ; Mongkolsapaya et al., 1999) . However, the techniques employed have been limited in their ability to provide precise quantitative information on MV-specific memory T-cells. Due to low precursor frequencies, enumeration of virus-specific memory T-cells in peripheral blood has been difficult. A prerequisite for detection of precursors was prior expansion of T-cell lines or clones before performing proliferation or cytotoxicity assays.
Recently, novel methods for quantifying antigen-specific Tlymphocytes at a single-cell level have been described. The use of tetrameric MHC-peptide complexes which bind specifically to appropriate T-cell receptors allows direct quantitative analysis of T-cell responses (Altman et al., 1996 ; Busch et al., 1998 ; Murali-Krishna et al., 1998 ; Crawford et al., 1998 ; . Alternatively, T-cells can be stimulated with epitope peptides and their IFN-γ production measured by ELISPOT assay or by intracellular flow cytometry (Scheibenbogen et al., 1997 ; Waldrop et al., 1997 ; Kern et al., 1998 ; Pitcher et al., 1999) . T-cell numbers detected with these tests were comparable to those determined by tetramer staining Flynn et al., 1998) . Experiments using one or more of these approaches to test humans infected with human immunodeficiency virus (HIV) or Epstein-Barr virus (EBV) and mice infected with lymphocytic choriomeningitis virus have shown very clearly that earlier methods depending on expansion of T-cells underestimated the prevalence of virus-specific T-cells by a factor of at least 10 (Altman et al., 1996 ; Butz & Bevan, 1998 ; Murali-Krishna et al., 1998 ; Tan et al., 1999 ; Pitcher et al., 1999) .
These new techniques allow analysis of either CD4 + T-cells with selected viral antigens or of CD8 + T-cells relying heavily on the knowledge of viral epitopes. In this study we describe a modified single-cell approach to simultaneously quantify immune responses of both virus-specific CD4 + and CD8 + Tcells which is independent of preselecting viral antigens or epitopes. This technique was used to quantify the frequency of memory T-cells after MV infection and compare it to EBVspecific memory T-cells.
Methods
Donor population. The donors in this study were eight healthy MV-seropositive adults, 25 to 42 years old, with no history of chronic disease or immunodeficiency. They were free from infection and received no drug therapy. In addition, cord blood was taken from three healthy full-term infants with no signs of congenital viral or bacterial infection. Blood was taken with the consent of the donors or their parents after the nature and possible consequences of the study had been fully explained. The study was approved by the ethical committee of the University of Wu$ rzburg.
Serology was assessed by standard enzyme immunoassay (EIA) for MV and EBV (Institute fu$ r Virologie und Immunobiologie, Wu$ rzburg, Germany).
Cell preparation. Samples (5 to 20 ml) of heparinized venous blood (20 U\ml heparin) were drawn and processed within 6 h of collection. Mononuclear cells were isolated on Ficoll-Hypaque density gradients (Pharmacia). Aliquots of isolated lymphocytes were stored in liquid nitrogen in the presence of 10 % DMSO and 20 % foetal calf serum.
Autologous B-lymphoblastoid cell lines (B-LCL) were established for each donor, 6 to 8 weeks before testing, from 5i10' PBMC by using the B95-8 strain of EBV and the -leucine methyl ester procedure (Thiele & Lipsky, 1985) .
For preparation of peripheral blood dendritic cells (DC) PBMC were isolated by Ficoll-Hypaque (Pharmacia) density gradient centrifugation from 100 ml of heparinized venous blood obtained from healthy adult donors. DC were isolated by adherence for 1 h in culture dishes (Becton Dickinson). DC were cultured in RPMI 1640 medium containing 10 % autologous serum with 800 units\ml granulocyte-macrophage colonystimulating factor and 1000 units\ml IL-4 for 7 days. Cells were harvested and infected in the same culture medium.
174iCEM.T2 cell lines were used with written consent from P. Cresswell (Yale University, New Haven, CT, USA). T2 cells are unable to present endogenously synthesized peptides due to a deficiency of TAP1 and TAP2 transporter genes and are MHC class II antigen negative (Salter & Cresswell, 1986) .
MV infection. The Edmonston strain of MV was grown in Vero cells (continuous African green monkey kidney cells).
Virus stocks contained 10' p.f.u.\ml. To prepare MV-infected antigen-presenting cells (APC), cells were infected with MV at an m.o.i. of 1. B-LCL were incubated for 24 h and DC for 72 h before they were used as APC. In order to get a recovery of more than 10 % from MV-infected DC, MV fusion inhibitory peptide (Sigma) (Richardson & Choppin, 1983) had to be added. Infection rate was monitored by cell surface expression of MV haemagglutinin protein using MAb clone L177.
Intracellular staining for IFN-γ. The protocol adopted was essentially that of P. Openshaw (Openshaw et al., 1995) . Briefly, PBMC were cultured in 96-well (round bottom) plates at a concentration of 2i10& cells per well without or with 1i10& B-LCL or 2i10% DC as APC. Brefeldin A (Sigma) at 2 µg\ml was added for the last 4 h of culture to stop cytokine secretion. After 16 h of culture cells were harvested, washed once by centrifugation in PBS with 0n02 % NaN $ and 0n2 % BSA (FACS buffer), and then stained with R-phycoerythrin (RPE)-conjugated anti-CD8 or anti-CD4 (Dako) and biotin-conjugated anti-CD3 (Immunotech). After removing unbound antibody cell-bound biotinylated anti-CD3 was stained with streptavidin Cy-Chrome (Pharmingen). After further washing cells were fixed in 2 % formaldehyde for 20 min and then washed again in FACS buffer. Permeabilization was then performed by incubating cells in PBS with 0n5 % saponin and 10 % BSA in PBS for 10 min. For intracellular staining a murine monoclonal fluorescein isothiocyanate (FITC)-conjugated anti-IFN-γ MAb clone, 15.45 (Ho$ lzel Diagnostik, Cologne, Germany), was used. For blocking experiments unconjugated antibody of the same clone was used. After intracellular staining cells were washed once in saponin buffer and then in FACS buffer. Samples were analysed on a FACScan flow cytometer (Becton Dickinson, Immunocytometry system). Lymphocytes were gated in side-scatter versus forward-scatter light ; CD3 + T-lymphocytes were gated in fluorescence 3. For frequency analysis 50 000 to 150 000 events per sample were measured.
IFN-γ-specific ELISPOT assay. ELISPOT assays for IFN-γ were performed with slight modifications after established protocols (Fujihashi Measles virus-specific memory T-lymphocytes Measles virus-specific memory T-lymphocytes et Sarawar & Doherty, 1994) . Briefly, 96-well nitrocellulosebased microtitre plates (Millititre HA ; Millipore) were coated overnight at 4 mC with the anti-IFN-γ MAb clone 1-D1-K at a concentration of 15 µg\ml in PBS (Ho$ lzel Diagnostik). After washing with PBS, 1i10& lymphocytes were added to the wells without or with 5i10% APC and incubated for 24 h at 37 mC. After the wells had been washed biotinylated anti-IFN-γ MAb clone 7-b6-1 (Ho$ lzel Diagnostik) was added, and incubated overnight at 4 mC. Plates were washed in PBS and anti-biotin MAb conjugated with streptavidin (ALP-PQ ; Ho$ lzel Diagnostik) was added, followed by 2 h incubation at room temperature. Spots representing individual IFN-γ-secreting cells were visualized by developing with an alkaline phosphatase conjugate substrate kit (Bio-Rad). Wellplates were photographed with a Wild Fotomakroskop M400 camera. Spots were counted after slide projection. All assays were performed in triplicate.
Optimal culture conditions were extensively studied when establishing the IFN-γ ELISPOT assay. Reproducible spots were obtained with an absolute number of 1 to 2i10& cells per well and with an effector to target ratio of 2 : 1. Furthermore, kinetic studies revealed that the number of IFN-γ-secreting cells did not increase when PBMC were incubated in our assay for periods progressively longer than 12 h (up to 30 h). However, the quality of spots was best after 24 h. At earlier periods spots were small and sometimes difficult to discriminate from background phenomena. Later, spots became fuzzy and confluent (data not shown).
Enrichment of CD4 M and CD8 M cell subsets. Separation was achieved with the MiniMACS separation system (Miltenyi Biotec). A suspension of up to 5i10( PBMC was incubated for 15 min at 4 mC with anti-CD4-or anti-CD8-conjugated magnetic beads (Miltenyi Biotec) and then separated by using the MiniMACS separation column according to the manufacturer's instructions. Cell-surface marker analysis with CyChrome-conjugated anti-CD3 MAb, PE-conjugated anti-CD8 MAb and FITC-conjugated anti-CD4 MAb was performed on enriched cells.
Results

In vitro activation of specific T-cells with MV-infected APC
For stimulation of MV-specific T-cells, an autologous cell system is required. MV has a tropism for cells of the lymphocytic and monocytic lineage (Esolen et al., 1993 ; Joseph et al., 1975) . Whereas DC as professional APC are most effective for induction of primary and secondary T-cell responses, B-LCL are readily available and have also been efficiently used as APC to induce secondary CD4 + and CD8 + T-cells. Therefore, DC and B-LCL were potential candidates as APC. However, after infection DC rapidly developed syncytia and decreased in numbers to less than 5 %, due to the lytic effects of MV. Therefore, to avoid formation of syncytia, fusion inhibitory peptide had to be added to cultures (Richardson & Choppin, 1983 ). Still, more than 100 ml of venous blood per experiment was needed when using DC as APC. In contrast, B-LCL were generated from 3 to 5 ml of venous blood. Once established they could be used indefinitely. Furthermore, under the conditions used more than 80 % of B-LCL were infected after 24 h whereas only 12 % of DC were positive after 72 h (Fig. 1) .
Next, we tested the ability of MV-infected B-LCL and DC to activate MV-specific T-cells. PBMC in the absence of APC BDBF R. Nanan and others R. Nanan and others produced no IFN-γ (data not shown). As shown in Fig. 1 , with MV-infected DC specific CD3 + CD4 + and CD3 + CD8 + T-cells could be induced to produce IFN-γ. In parallel experiments with MV-infected B-LCL as APC there was also an MVspecific T-cell response in both T-cell subsets. However, uninfected B-LCL also induced IFN-γ production in PBMC. Most likely, B-LCL express latent EBV antigens which activate EBV-specific T-cells. Therefore, when calculating MV-specific T-cell frequencies EBV-specific T-cells have to be subtracted. Consistently, frequencies of MV-specific T-cells obtained with MV-infected B-LCL as APC were comparable to frequencies assessed with DC for both CD3 + CD4 + and CD3 + CD8 + Tlymphocyte subsets. Representative results from three experiments are given in Fig. 1 .
Frequencies of IFN-γ-positive cells were highly reproducible from multiple independent assays performed by splitting individual blood samples as well as from longitudinal samples, as shown in Fig. 2 . Thus, for further experiments B-LCL were used as APC. Fig. 3 . MHC restriction and specificity of CD3 + CD4 + and CD3 + CD8 + T-lymphocyte subsets were tested (donor A) by intracellular IFN-γ staining. Autologous B-LCL were used as APC. These cells were either uninfected, infected with MV, mockinfected with Vero cell supernatant or incubated with inactivated MV (heat-treated for 60 min at 56 mC). Cells of the 174iCEM.T2 cell line were also used uninfected or MV-infected as APC. 
MHC restriction and virus-specificity of IFN-γ-positive cells
We further investigated MHC restriction of MV-specific Tcells using 174iCEM.T2 cell lines as APC. These cells are deficient for endogenous MHC class I peptide loading and express no MHC class II molecules. As shown in Fig. 3 , there was no MV-specific T-cell response when these cells were used as APC.
In addition, we tested whether replication of virus was needed for induction of CD8 + T-cells. For this purpose, autologous B-LCL were incubated with heat-inactivated MV and used as APC. As shown, there was a clear response of MHC class II-restricted CD4 + T-cells which recognize non-BDBG Table 1 . Virus-specific T-cells in seropositive and seronegative donors Virus-specific cells are given as percentages of T-cell subsets. EBV-specific T-cell subsets were calculated as : (IFN-γ-positive T-cell subsets in cultures with B-LCL)k(IFN-γ-positive T-cell subsets in cultures without B-LCL). MV-specific T-cells were calculated as : (IFN-γ-positive T-cell subsets in cultures of MV-infected B-LCL)k(IFN-γ-positive T-cell subsets in cultures with uninfected B-LCL). Background levels of IFN-γ-positive T-cell subsets in cultures without APC were less than 1 in 10 000 PBMCs. Titres of virus-specific IgG antibody were determined by EIA and expressed in international units (IU)\ml. Cut-off for negative serology was 25 IU\ml. Material from donors (I)-(K) was cord blood. Neg., negative ; , not determined. replicative antigens, but not of MHC class I-restricted CD8 + Tcells for which de novo synthesized antigens are required (Fig. 3) .
Virus
Comparison of T-cell frequencies by intracellular IFN-γ staining and ELISPOT assay
Both CD3 + CD4 + T-cells as well as CD3 + CD8 + T-cells were analysed for IFN-γ expression by intracellular staining. To verify intracellular IFN-γ production by an alternative approach, IFN-γ ELISPOT assays were performed. CD4 + -and CD8 + -enriched T-cells were analysed separately. Frequencies of MV-specific T-cell subsets were comparable in both assays in multiple independent experiments (Fig. 4) .
Specificity of IFN-γ secretion by MV-specific T-cells
To exclude a non-specific stimulation of MV-specific Tcells by B-LCLs the following controls were performed (Table  1) . Cord blood lymphocytes from healthy full-term infants without contact with either EBV or MV did not display a virusspecific response. T-cells from two EBV-seronegative, MVseropositive donors secreted IFN-γ after stimulation with MVinfected stimulator cells but not after stimulation with B-LCLs alone. We also observed a strict association between seropositivity and T-cell response to both EBV and MV. Indeed, the correlation between MV-specific CD4 + T-cells and MVspecific antibody titres was significant (linear regression analysis, r l 0n8) ( Table 1) .
Frequency of MV-specific T-cells in healthy adults with a childhood history of measles
MV-specific T-cells were evaluated in a group of eight MVseropositive individuals with a known history of natural measles in childhood (Table 1) . Six of these donors were also EBV-seropositive. MV-seropositive adult donors had a median frequency for MV-specific CD3 + CD4 + T-cells of 0n35 %, ranging from 0n08 to 0n85 %. For the CD3 + CD8 + T-cell subset the median frequency was 0n24 %, ranging from 0n05 to 0n48 %.
In parallel, EBV-specific T-cells were evaluated also. The median frequency of EBV-specific CD4 + T-cells was 0n08 %, with a range of 0n01 to 0n2 %, and for CD8 + T-cells 0n14 %, with a range of 0n08 to 0n32 %.
Discussion
In this study we quantified CD3 + CD4 + and CD3 + CD8 + MV-specific T-lymphocytes in PBMC. T-cell responses strictly correlated with seropositivity and were clearly antigen-specific. They occurred in the appropriate T-cell subset and depended on MHC-restricted antigen presentation.
Our modified single-cell quantitative approach has several important advantages over earlier methods to analyse T-cell frequencies which required previous expansion of T-cells. First, R. Nanan and others R. Nanan and others this assay identifies and quantifies antigen-responsive T-cells within 16 h of culture and is independent of T-cell proliferation. Thus, cell cycle arrest induced by infectious MV in vitro becomes irrelevant for this assay.
Second, synthetic peptides have previously been used in a tetramer technique as well as with IFN-γ ELISPOT and intracellular staining assays. However, these techniques mostly rely on the knowledge of epitopes in the context of selected MHC molecules and involve laborious construction of the appropriate reagents. In contrast, in our approach using MVinfected autologous APC, immune responses against viral antigens in the context of all MHC alleles are measured. This has the practical consequence that MHC typing can be omitted, allowing clinical investigation of T-cell responses of virtually any donor population from small samples of blood.
Third, in our experiments whole virus was used as antigenic challenge. Thus, viral proteins go through the antigenprocessing machinery and might be presented in a more physiological context on APC than when adding exogenous peptide in artificially high concentrations.
Furthermore, using MV-infected APC allows simultaneous analysis of MHC class I-and II-restricted T-cells. Thus, subset assignment of antigen-specific responses allows the coevaluation of CD4 + and CD8 + T-cells.
For humans, frequency data are available from individuals with persistent virus infections such as EBV, CMV and HIV. For detection of virus-specific CD4 + T-cells, most investigators used intracellular cytokine staining. Flow cytometric assays exhibited a median frequency of 0n71 % (range 0n15 to 2n3%) IFN-γ-producing CD4 + T-cells in normal CMV-positive subjects (Waldrop et al., 1997 ; Kern et al., 1998) . In nonprogressive HIV patients CD4 + memory T-cells were found with a median frequency of 0n40 % (range 0n1 to 1n7 %) (Pitcher et al., 1999) .
Frequency analysis of virus-specific CD8 + memory T-cells was mainly performed by tetramer staining and by intracellular IFN-γ staining. Here, for CMV-derived dominant peptide epitopes memory CD8 + T-cell frequencies were between 0n3 and 3 % (Kern et al., 1998) and for EBV-specific CD8 + T-cells between 0n03 and 3n8 % (Callan et al., 1998 ; Tan et al., 1999 ; Dalod et al., 1999 a, b) .
In contrast to persistent viral infections, information on human memory T-cell frequencies for non-persistent infections are mainly based on studies using limiting dilution assays, which markedly underscored T-cell frequencies. In this study, for the first time, virus-specific memory T-cell subsets were simultaneously analysed for a non-persistent virus infection with a single-cell approach. Surprisingly, the frequencies of MV-specific CD4 + and CD8 + memory T-cells found are comparable to those previously reported for persistent virus infections such as EBV, CMV or HIV. Thus, even decades after acute measles both the CD4 + and CD8 + T-cell pools contain high levels of MV-specific memory T-cells. This indicates that cell-mediated immunity to MV is long-lived and might be independent from virus persistence. Whereas in persistent virus infections both CD4 + and CD8 + T-cells have been shown to be critical for maintenance of memory, the interdependence of these T-cell subsets for lasting immunity to non-persistent infections has not been studied (Kalams & Walker, 1998 ; Zajac et al., 1998) . It is therefore of special interest that after natural MV infection comparable levels of MV-specific memory CD4 + and CD8 + Tcells were found. Thus, we suggest that immunity to measles also requires a balanced ratio of virus-specific T-helper to cytotoxic memory T-cells. However, further investigations will reveal whether comparable frequencies of MV-specific Tcell subsets are also detected after immunization with live attenuated MV or when analysing T-cell subsets in patients with measles complications such as acute encephalitis or subacute sclerosing panencephalitis. Hence, this approach will be useful in determining the immunological factors that decide the outcome of the disease and which lead to lifelong immunity in measles.
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